Delivery Order SPE2DB20D1047-SPE2DB25FF59H
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,257.04, is for the delivery of the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 300ML" and has a completion date of April 15, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565564813 - KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The $2,554.56 contract has an ultimate completion date of August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, was selected to provide these critical medical supplies without any set-aside designation. This delivery order is likely part of a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The contract, valued at $2,532.72, is a firm fixed-price delivery order with an ultimate completion date of August 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This delivery order is part of a...
This federal contract award, valued at $1,399.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product, under a Firm Fixed Price contract type. The contract has an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a prescription medication, with a ceiling value of $1,641.14 and a period of performance through April 30, 2025. The contract is not set-aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,428.00 firm fixed price contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a prescription medication, to support federal healthcare programs and facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The order is for the supply of 300 ml oral suspension of the drug KONVOMEP 2-84 mg/ml, with a ceiling value of $6,729.12 and a period of performance through April 9, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract...
This federal contract award, valued at $1,903.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, designated as SPE2DB20D1100|SPE2DB25FB9B5, is a delivery order contract for the supply of the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 300ML". The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The $5,227.50 firm fixed price contract is to provide the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 150ML" with a completion date of May 1, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
Defense Logistics Agency Troop Support Medical awarded a $357 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for 4562455894 KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, to be performed in Conshohocken, Pennsylvania with an anticipated completion date of October 13, 2023. As no set-aside designation was used, this appears to be an open market procurement to fulfill pharmaceutical needs for DLA Troop Support Medical...